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A B S T R A C T
Conducting polymers (CP), namely polyaniline (PANI) and polypyrrole (PPy), are promising materials applicable
for the use as biointerfaces as they intrinsically combine electronic and ionic conductivity. Although a number of
works have employed PANI or PPy in the preparation of copolymers, composites, and blends with other poly-
mers, there is no systematic study dealing with the comparison of their fundamental biological properties. The
present study, therefore, compares the biocompatibility of PANI and PPy in terms of cytotoxicity (using NIH/3T3
fibroblasts and embryonic stem cells) and embryotoxicity (their impact on erythropoiesis and cardiomyogenesis
within embryonic bodies). The novelty of the study lies not only in the fact that embryotoxicity is presented for
the first time for both studied polymers, but also in the elimination of inter-laboratory variations within the
testing, such variation making the comparison of previously published works difficult. The results clearly show
that there is a bigger difference between the biocompatibility of the respective polymers in their salt and base
forms than between PANI and PPy as such. PANI and PPy can, therefore, be similarly applied in biomedicine
when solely their biological properties are considered. Impurity content detected by mass spectroscopy is pre-
sented. These results can change the generally accepted opinion of the scientific community on better bio-
compatibility of PPy in comparison with PANI.
1. Introduction
The impact of bioelectricity on physiological processes can be ob-
served either on the level of individual cells, e.g., the stem cell differ-
entiation [1] and cell movement [2], or on the level of tissues, e.g., the
physiology of electro-sensitive tissues or wound healing [3]. In the
preparation of a biocompatible biointerface, the combination of elec-
tronic and ionic conductivity is one of the key parameters; in this re-
spect, conducting polymers (CP) are considered to be an excellent so-
lution as they inherently combine both of these types of conductivities
[4]. Though polyaniline (PANI) and polypyrrole (PPy) are the most
studied conducting polymers, and there are a number of studies dealing
with their preparation, characterization, and physico-chemical prop-
erties, the works which focus on their comparison are scarce as regards
their chemistry [5,6] and especially their biological properties [7,8].
Both PANI and PPy have been used extensively for the preparation
of composites with other materials and subsequently tested in terms of
their biological properties, such as their in vivo capacities to cause
reactions in tissues [9,10]. In spite of this, however, there are few
studies describing the biological properties of pure PANI (e.g. in the
form of powder [11]; colloids [12] or films [13,14]) or PPy [15]. This
lack of knowledge is critical if biologically-oriented applications are to
be considered.
The crucial characteristic of any material used in tissue engineering
is its biocompatibility. It is very well known that biocompatibility is a
complex characteristic combining a range of individual biological
properties which are preferably tested using alternative invitromethods.
Although invitro experiments can provide valuable information, its in-
terpretation still presents a challenge, as any model (such as different
cell lines) can behave differently and different conclusions can there-
fore be drawn. When comparing results published in literature, inter-
laboratory variations in assay performance must also be considered, as
the number of tests is not validated and each laboratory can apply a
slightly different experimental set-up. For example, such variation and
inconsistency can occur as a result of the procedures for handling em-
bryonic stem cells in individual laboratories. The presented work is,
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therefore, aimed at performing and discussing a complex comparative
study of the fundamental biological impacts of PANI and PPy on NIH/
3T3 fibroblasts, embryonic stem cells (ESc), and embryoid bodies (EBs)
observed under the same conditions. Fibroblasts were chosen as they
are the most frequently used line for the determination of cytotoxicity;
ESc are a lineage with considerable potential for application in bio-
medicine and tissue engineering thanks to their naive phenotype and
ability to differentiate into a variety of cell lineages; and the choice of
EBs was motivated by the fact that their interaction with materials can
be used as a marker of embryotoxicity.
The motivation for this study emerged from long term experience
with CP and because PPy is understood by the scientific community to
be more biocompatible than PANI even though the supposed super-
iority of PPy is not based on any experimental data.
2. Material and methods
2.1. Preparation and characterization of polymers
Polyaniline salt (PANI-S) was prepared using a standard procedure
[16]. Specifically, a 0.2 M aqueous solution of aniline hydrochloride
(Penta, Czech Republic) was oxidized with 0.25M ammonium perox-
ydisulfate (APS; Penta, Czech Republic). Polymerization was carried
out at room temperature for 12 h. The resulting green solids of poly-
aniline salt were collected on a filter, rinsed with 0.2 M hydrochloric
acid, and similarly with acetone, and dried at room temperature over
silica gel.
Polypyrrole salt (PPy-S) was synthetized by oxidizing 0.2 M pyrrole
(Sigma-Aldrich) with 0.5M iron (III) chloride hexahydrate (Sigma-
Aldrich) in an aqueous environment. The oxidant to pyrrole mole ratio
was 2.5. The mixture was left to polymerize at room temperature for
12 h. The black solids were collected on a filter and, similarly to PANI-S,
rinsed with 0.2M hydrochloric acid followed by acetone, and dried at
room temperature over silica gel.
A part of both, PANI-S and PPy-S were deprotonated to polyaniline
base (PANI-B) and polypyrrole base (PPy-B) by immersing the solids in
an excess of 1M aqueous ammonium hydroxide. SEM photo-
micrographs were captured using a JEOL 6400 microscope.
2.2. Preparation of polymer extracts
Samples were extracted according to a modification of protocol ISO
10993-12. The modification of the standard procedure involved the
ratio between the mass of the extracted samples and the volume of the
extraction medium. The standard procedure employs 0.2 g polymer per
1mL cultivation medium. As the PPy samples were very fluffy and
extremely difficult to separate from the medium after extraction, the
ratio of 0.05 g of powder per 1mL of cultivation medium was used for
all tested samples. In this way a sufficient volume of each polymer
extract was obtained for testing. Extraction was performed in chemi-
cally inert closed containers using an aseptic technique at 37 ± 1 °C
under stirring for 24 h. The extracts were separated from the powders
by double centrifugation at 1000 g for 15min. The parent extracts
(100%) were then diluted in a complete medium to obtain a series of
dilutions with concentrations of 1, 5, 10, 25, and 50%. All extracts were
used within 24 h. Prior to in-vitro testing, the samples were disinfected
by means of sterile filtration through a 0.22 μm syringe filter
(Millipore). Each of the concentrations was tested in quadruplicates, in
four separate sets of experiment.
For mass spectroscopy analyses, the polymers were extracted using
the procedure described above, but with deionized water as the ex-
traction medium.
2.3. Characterization of polymer extracts
Aqueous polymer extracts were analysed using a 1260 Series liquid
chromatography system (Agilent Technologies, Santa Clara, CA) cou-
pled to a 6520 Accurate-Mass Q-TOF mass spectrometer (Agilent
Technologies, Santa Clara, CA) equipped with a dual-spray electrospray
ionization source. Aliquots of 5 μL were injected as an infusion into the
system with no column installed. Compounds were eluted at 30 °C with
an isocratic flow rate of 0.3mLmin−1 of 1% (v/v) formic acid in water.
The positive ion mode mass spectrometry conditions were as follows:
gas temperature, 300 °C; fragmentor voltage, 75 V; capillary voltage,
3.000 V; nozzle voltage, 2000 V; scan range m/z 50 to 1700; 1 scan/s.
The internal mass reference ions m/z 121.050873 and m/z 922.009798
were used to keep the mass axis calibration stable during the analysis.
2.4. Cell lines and media
2.4.1. Mouse embryonic fibroblast cell line NIH/3T3 (ATCC CRL-
1658TM)
ATCC–formulated Dulbecco's Modified Eagle's Medium, catalogue
no. 30-2002, with added calf serum (BioSera, France) to a final con-
centration of 10% and penicillin/streptomycin, 100 UmL−1 (GE
Healthcare HyClone, UK) was used as the culture medium.
The embryonic stem cell ES R1 line (ESc) [17] was propagated in an
undifferentiated state by culturing on gelatinized tissue culture dishes
in complete media. The gelatinization was performed using 0.1% por-
cine gelatine. Complete media containing Dulbecco's Modified Eagle's
Medium (DMEM), 15% fetal calf serum, 100 UmL−1 penicillin,
0.1 mgmL−1 streptomycin, 1× non-essential amino acids solution (all
from Gibco-Invitrogen; USA), 0.05mM 2-mercaptoethanol (Sigma–Al-
drich; USA), and 1000 UmL−1 leukemia inhibitory factor (Chemicon;
USA) were used for the cultivation [13].
2.4.2. Cytotoxicity on ES R1 and NIH/3T3 cell lines
Cytotoxicity testing was performed according to ISO protocol 10
993-5. Cells were pre-cultivated for 24 h and seeded at a density of
5000 cells per cm2 in the case of ESc or 12,000 per cm2 in the case of
NIH/3T3. The extracts were applied onto cells for 48 h (ESc) or 24 h
(NIH/3T3). To assess the cytotoxic effects of PANI and PPy extracts on
ESs, the mass of viable cells was determined as the level of ATP using
Cellular ATP Kit HTS (Biothema, Sweden). Samples were prepared and
analysed as published [18]. Before lyses, the morphology of the cells
was observed and documented using an inverted Olympus phase con-
trast microscope (Olympus IX51, Japan) fitted up with a digital camera
(Olympus E-450, Japan). To assess the viability of NIH/3T3 cells, MTT
assay was used [19]. As a reference giving 100% cell viability, cells
cultivated in pure complete media were used. The results are presented
in two different ways. In addition to the strict processing of data ac-
cording to the requirements of ISO 10 993-5 standard, statistical eva-
luation was also conducted using one-way analysis of variance ANOVA.
ATP and MTT assays were evaluated using a Luminometer Infinite
m200pro (Tecan, Switzerland).
2.4.3. Embryotoxicity
Embryotoxicity was determined as the likelihood of the formation of
beating foci (the impact on cardiomyogenesis) and erythroid (red) clusters/
colonies (the impact on erythropoiesis) within spontaneous differentiating
ESc after exposure to the studied extracts. ESc differentiation was induced
through the formation of embryoid bodies (EBs) by hanging drop techni-
ques (400 cells per one 35 μL drop) in leukemia-inhibitory-free complete
media described in ([20]. After 5 days, EBs were transferred to a gelatinized
24-well plate (one EB per well) in serum-free medium for the next 15 days
and the medium was replaced with fresh medium every three days. Serum-
free medium contained DMEM-F12 medium (1:1), 100UmL−1 penicillin,
0.1 gmL−1 streptomycin, and 1× insulin-transferrin-selen (ITS) supplement
(all from Gibco-Invitrogen; USA). Differentiating cells were observed and
documented using an inverted Olympus phase contrast microscope
(Olympus IX51, Japan) equipped with digital camera (Olympus E-450,
Japan) [13].
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3. Results and discussion
Each of the studied polymers was synthesized using the most
common preparation procedure employed within the chemical oxida-
tion routes. Therefore, PANI was synthetized using the oxidation of
aniline hydrochloride with ammonium persulfate according to the re-
spective IUPAC protocol [16], and PPy was prepared via the oxidation
of pyrrole with iron(III) chloride, which is the oxidant of first choice in
the preparation of this polymer (Fig. 1) [21,22].
There is a common opinion in the scientific community and
literature that PPy is more biocompatible than PANI. This generally
accepted opinion is, however, based on indirect comparisons of
studies conducted on these polymers [23]. The present study is the
first to compare the biological properties of these two most im-
portant CP determined under the same conditions, using the same
cell lineages and methodology, and performed in the same labora-
tory. The results are therefore unique and difficult to compare
meaningfully with those published in any previous works. Previous
Fig. 1. The morphology of PANI-S and PPy-S visualized by SEM.
Fig. 2. Cytotoxicity of extracts of PANI and PPy towards NIH/3T3 cells determined by MTT assay. The different superscripts correspond to significant differences
(P≤ 0.05) compared to the reference. The dashed lines highlight the limits of viability according to EN ISO 10993-5: viability> 0.8 corresponds to no cytotoxi-
city,> 0.6–0.8 mild cytotoxicity, > 0.4–0.6 moderate cytotoxicity and< 0.4 severe cytotoxicity.
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studies mainly investigated these polymers separately, using dif-
ferent methodologies, test protocols, and ways of processing the
results obtained. Moreover, most of these works do not examine
these CP alone, but their composites or blends with other thermo-
plastic polymers [24,25].
Therefore, the motivation of this study was to provide a compre-
hensive view of the biological properties of PANI and PPy as a base line
for additional advanced studies dealing with the exploitation of these
promising CP in biomedicine, regenerative medicine, and biosensors in
electro-sensitive tissues.
Cytotoxicity tests are the test of first choice when the biocompatibility of
materials, including polymers, is evaluated. According to the EN ISO 10993
protocol, mouse fibroblasts are the cells most commonly used to determine
the cytotoxicity of polymers after the application of their extracts. Due to
advances in the biomaterial sciences, ESc are also frequently used to de-
termine and evaluate the biocompatibility of materials and products. Thus,
the cytotoxicities of PANI and PPy were determined not only using NIH/3T3
fibroblasts but also ESc. The results regarding NIH/3T3 cells are presented
in Fig. 2 and illustrate that the extracts of both salts, PANI-S and PPy-S, lost
their cytotoxicity at concentrations of 5% and below. In contrast, PPy-B did
Fig. 3. Cytotoxicity of extracts of PANI and PPy on ESc determined by the relative level of ATP compared to the reference. The different superscripts correspond to
significant differences (P≤ 0.05) compared to the reference. The dashed lines highlight the limits of viability according to EN ISO 10993-5: viability> 0.8 cor-
responds to no cytotoxicity, > 0.6–0.8 mild cytotoxicity, > 0.4–0.6 moderate cytotoxicity and< 0.4 severe cytotoxicity.
Fig. 4. The cytotoxicity of a tested sample towards ESc. A) reference, B) cytotoxic effect observed after the application of the 5% extract of PPy-S. Cell destruction
after the application of PPy extract is obvious. Magnification: 100×.
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not induce any cytotoxicity, even when NIH/3T3 cells were cultivated in the
presence of 50% extract; in the case of PANI-B the corresponding effect was
observed at an extract concentration of 25%. The results unambiguously
illustrate that PANI and PPy in their base form are notably less cytotoxic
than both polymers in the form of salts. With respect to ECs (Figs. 3 and 4),
the results were very similar to those for NIH/3T3 cells. That is, both bases
exhibited notably lower cytotoxicity in comparison with the corresponding
salts.
The embryotoxicity of PANI and PPy was studied with respect to the
spontaneous differentiation of ES R1 cells using two parameters,
namely the formation of beating foci, which is a marker of cardio-
myogenesis, and the formation of erythroid clusters as a marker of er-
ythropoiesis.
The results of the embryotoxicity test summarised in Table 1 show
only minor differences within the two sets of samples, namely when the
PANI-S with PPy-S and PANI-B with PPy-B are compared. Both PANI-B
and PPy-B performed equally and the levels of formation of beating foci
and erythroid clusters even corresponded to the reference. Therefore, it
was not possible to determine the threshold concentration of extract at
which cardiomyogenesis or erythropoiesis were influenced by these
polymer extracts. The impacts of the PANI-S and PPy-S were, however,
different, and their extracts terminated cardiomyogenesis and ery-
thropoiesis in all EBs at a concentration of 25% in cultivation medium.
The example of erythroid clusters formation is shown on the Fig. 5. The
most adverse effect on erythropoiesis was exhibited by the PPy-S, which
was capable of terminating 25% EB at an extract concentration of 1%.
Similarly to cytotoxicity, bigger differences were observed between the
behaviours of the respective salts and bases than between the pure
forms of PANI and PPy.
To the best the authors' knowledge, there is only one previously
published comprehensive study focused on the cytotoxicity of PANI in
its native globular form [11] and one study dealing with the cytotoxi-
city of PPy prepared by the standard oxidation method [10] including
both in-vitro and in-vivo investigations. In both of these studies,
biocompatibility was assessed using extracts of polymers in culture
medium or saline. There are also other studies concerning the cyto-
toxicity of PPy, but focused on their nanoparticle form [26,27], which
make their results non-comparable to ours as the methodology of pre-
paration is different. It is also well known that cytotoxicity of nano-
particles is different from that of the polymer in globular form and, in
addition to chemical composition, it depends also on size and shape of
the nanoparticles.
As mentioned above when describing the methods used for in-
vestigating the biological properties of PANI and PPy, a ratio of 0.05 g
to 1mL−1 of cultivation medium instead of the ISO-defined ratio of
0.2 g to 1mL−1 was used to prepare the extracts of all samples in the
test. The reason for this modification was the difficulty of separating
PPy from the supernatant (medium) after polymer extraction. For the
sake of comparison, PANI extracts were prepared in the same manner.
The different starting concentrations of extracts obtained in this work
make meaningful comparison of our results with those in literature
somewhat complicated. Nevertheless, the comparison was performed
and the current results were correlated with those reported by
Humpolíček et al. [11] who investigated cytotoxicity of standard ex-
tracts (0.2 g to mL−1) of PANI salt and PANI base. For comparison
purposes, it can be considered that concentrations of extracts from
current work are one-fourth of the concentrations prepared by standard
procedure. In the work of Humpolíček, the cytotoxicity towards HaCaT
and HepG2 cells was determined, revealing non-cytotoxic threshold
concentrations of 1% for PANI-salt and 10% for PANI-base. These re-
sults are in accord with those observed for NIH/3T3 and ESc in the
current study, which showed an absence of cytotoxicity at extract
concentrations of 5% for PANI-S and 25% for PANI-B. When con-
sidering the use of different cell lines in both studies and fact that
correlation of cytotoxicity with concentrations of impurities in an ex-
tract may not always be strictly linear, it can be concluded that the
cytotoxicities of PANI-S and PANI-B, as determined in the current study,
are similar.
The biocompatibility of PPy was determined by Wang et al. [10]
using PPy-salt extracted at a ratio of 1 g to 10mL saline, according to
ISO protocol 10,993. Their work demonstrated that the viability and
proliferation rates of Schwann cells in the presence of PPy extract in
culture medium at a concentration of 25% (in the original article, re-
ferred to as 100 μL of 50% extract and 100 μL of cultivation medium)
even improved in comparison with the control sample containing a
corresponding amount of saline solution in medium, and equalled the
cell behaviour in plain medium. The authors hence concluded that the
polymer extract exhibited the absence of cytotoxicity. The current
study, however, showed that PPy-S samples were cytotoxic down to a
concentration of 5% and that cytotoxicity was reduced by transferring
PPy-S to its base form (PPy-B), which was non-cytotoxic in the presence
of 50% extract. Though the polymers from these two studies were
prepared by the oxidation of pyrrole with FeCl3, different concentra-
tions and ratios of individual monomers were used during syntheses;
moreover, Wang et al. provided no information on the purification of
the polymer used.
Table 1
Cardiomyogenesis or erythropoiesis observed after contact of ES R1 ECs with
PANI and PPy extracts. Results are expressed as a number of beating foci or
erythroid clusters relative to the reference.
Formed beating foci [%]
Extract concentration [%] PANI-S PANI-B PPy-S PPy-B
Reference 100 100 100 100
1 100 100 100 100
5 50 100 75 100
25 0 100 0 100
Formed erythroid clusters [%]
Reference 100 100 100 100
1 100 100 75 100
5 13 100 50 100
25 0 100 0 100
Fig. 5. The formation of erythroid clusters (red
cluster marked with arrow) within the embryoid
body. A) positive reference; B) absence of the red
erythroid cluster after cultivation in the presence of
25% extracts of PANI-S. Magnification 100×. (For
interpretation of the references to color in this figure
legend, the reader is referred to the web version of
this article.)
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It is, however, much more important that, according to the results in
Figs. 2 and 3, the cytotoxicities of PANI and PPy in their respective
forms are comparable. To be more specific, the cytotoxicity depends
more on the form of PANI or PPy (salt vs base) than on the type of
polymer (PANI vs PPy). It should, however, be stressed that the current
work covers only the most commonly used ways of synthesizing these
conducting polymers. Considering other possible oxidation agents,
whether of chemical or biological origin, the situation with respect to
cytotoxicity might be different.
The impact of PANI and PPy on erythropoiesis and cardiomyogen-
esis has never been studied before. Nevertheless, it can be concluded
that the threshold concentrations at which embryogenesis processes are
influenced correlate with the cytotoxicities of individual polymer ex-
tracts. Similarly to cytotoxicity, embryogenesis and cardiomyogenesis
depends more on the form of polymer (salt vs base) than on its type
(PANI vs PPy).
As already mentioned, systematic work was previously undertaken
to determine the reasons for the cytotoxicity of PANI. Based on the
work of Stejskal et al. [28] and Kašpárková et al. [29] it can be assumed
that such cytotoxic effects are mainly connected with the presence of
low-molecular-weight impurities. In order to improve our view of the
correlation between biocompatibility and the contents of impurities,
Fig. 6. Mass spectra of PANI-S and PANI-B samples.
Fig. 7. Mass spectra of PPy-S and PPy-B samples.
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mass spectroscopy analyses of the studied samples were conducted with
the aim of obtaining an insight into the structures of impurities ex-
tracted from polymers that might be responsible for their cytotoxic
effects. The mass spectra of PANI-S and PANI-B are presented in Fig. 6.
As can be seen, the samples contain a relatively rich mass profile with
several major molecular ions (M+H)+. By comparison, it can be noticed
that the PANI-S sample comprises slightly more fractions with mole-
cular weights higher than 700 gmol−1 than the PANI-B sample. On the
other hand, PANI-B exhibits a more complicated mass profile especially
in the region 300–550m/z. Although many signals of various intensities
are present in both samples, it is obvious that PANI-B contains masses
not found in PANI-S, such as those in the low m/z region – for example,
199.1101 and 233.0700. Of all the masses present, only the following
were identified in PANI-S: aniline (m/z=94.0645), p-benzoquinone
imine (m/z=108.0682), and p-aminophenol (m/z=110.0599). Also
tetramer (m/z=290.1297, [30]) and quinoneiminoid structure (m/
z=290.1297) proposed by Kříž et al. [31], and Stejskal and Trchová
[32] were assigned as possible impurities present in the extract.
As shown in Fig. 7, both PPy extracts exhibited much simpler mass
spectra than extracts of PANI. In PPy-S and PPy-B, one dominant ion,
m/z=325.2275, was found, while higher masses were detected only
with low intensities, in particular in PPy-S extracts. The substance
corresponding to this mass, however, is probably non-cytotoxic as it is
present in both samples. An interesting question therefore arises as to
which of the substances present in PPy-S are involved in cytotoxic ef-
fects.
After careful inspection of MS data, it can be concluded that it was
not possible to detect linear oligomers as possible impurities, as they
were probably absent from the samples. The exact masses calculated,
however, indicate that the impurities extracted from the samples
comprise oxygen and that, therefore, oxygen containing by-products
are probably the most frequent impurities in the samples.
In spite of the limited success of MS in identifying impurities in
PANI and PPy, these spectroscopic analyses showed that both PANI-B
and PPy-B contain lower numbers and amounts of impurities and have
relatively simple impurity profiles. The reduced contents of impurities
logically reflect the process to which both polymers are subjected
during the transformation from salt to base. The process of re-proto-
nation can, therefore, be considered as an additional purification step
removing substances with potentially cytotoxic effects.
4. Conclusion
It is generally accepted in the scientific community that polypyrrole
shows more favourable biological properties than polyaniline, which is
reflected by prevalence of publications dealing with the first mentioned
polymer. Until now, however, no study provided direct comparison of
these two polymers in terms of their biological properties recorded
under the same conditions. Therefore, both polypyrrole and polyaniline
were synthetized by the most common procedures and studied within
one laboratory to eliminate the inter-laboratory differences. Two
parameters of biocompatibility were studied; the first, basic one - cy-
totoxicity was investigated using common fibroblasts NIH/3T3 cell line
and embryonic stem cells. The second, advanced parameter - embry-
otoxicity was studied in terms of the impact of each of the polymers on
the erythropoiesis and cardiomyogenesis within the embryonic bodies.
The direct comparison of both polymers using the same methodology
showed that the form of the polymer (salt vs base) is more important
than its type (polypyrrole vs polyaniline) when cytotoxicity and em-
bryotoxicity are taken into consideration. Especially the polymers in the
form of bases proved low cytotoxicity and embryotoxicity. To clarify
the reasons for determined differences in biological properties of
polyaniline and polypyrrole, the mass spectroscopy was used to de-
termine their impurity profiles. The detected impurities can't, however,
fully explain observed differences. For example, with respect to pre-
sence of major molecular ions, the extract of polypyrrole base exhibited
simpler mass spectra in comparison with extract of polyaniline base.
However, as it was already mentioned their biological properties were
similar. Therefore, the presented results should mainly provoke the
scientific community to compare also other biological properties of
both conducting polymers as, according to currently presented results,
they are more similar than previously assumed and their application
potential can be, at least, comparable.
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